Pregnancy in Takayasu Arteritis Patients Exposed to Anti-Tumour Necrosis Factor (Anti-TNF)-α Therapy
DOI:
https://doi.org/10.17140/GOROJ-2-122Abstract
First patient, a 35 year old woman with a diagnosis of ulcerative colitis since childhood, was diagnosed with TA in 2009. She had an uncomplicated pregnancy in 2004. When she planned a second pregnancy, she was receiving IFX7 mg/kg every-six-weeks plus chronic therapy.
References
Tombetti E, Di Chio M, Sartorelli S, et al. Systemic pen-traxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther. 2014; 16: 479. doi: 10.1186/s13075-014-0479-z
Hata A, Noda M, Moriwaki R, Numano F. Angiographic find-ings of Takayasu arteritis: new classification. Int J Cardiol. 1996; 54 Suppl: S155-S163. doi: 10.1016/0167-5273(96)02651-4
Mason JC. Takayasu arteritis-advances in diagnosis and man-agement. Nat Rev Rheumatol. 2010; 6: 406-415. doi: 10.1038/ nrrheum.2010.82
Sivakumar R, Misra R, Danda D, Mahendranath KM, Bacon PA. Development of an index to assess disease-related damage in takayasu arteritis and use in outcome of vascular interven-tions. Rheumatology. 2012; 51: 3140-3184.
Tanaka H, Tanaka K, Kamiya C, Iwanaga N, Yoshimatsu J. Analysis of pregnancies in women with Takayasu arteritis: com-plication of takayasu arteritis involving obstetric or cardiovas-cular events. J Obstet Gynaecol Res. 2014; 40: 2031-2036. doi: 10.1111/jog.12443
Ramirez GA, Maugeri N, Sabbadini MG, Rovere-Querini P, Manfredi AA. Intravascular immunity as a key to systemic vas-culitis: a work in progress, gaining momentum. Clin ExpImmu-nol. 2014; 175: 150-166. doi: 10.1111/cei.12223
Chaparro M, Gisbert JP. How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel dis-ease? Expert Opin Drug Saf. 2014; 13(12): 1749-1762. doi: 10.1517/14740338.2014.959489
Calligaro A, Hoxha A, Ruffatti A, Punzi L. Are biological dru-gs safe in pregnancy? Reumatismo. 2015; 66(4): 304-317. doi: 10.4081/reumatismo.2014.798
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.